This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Development Remove Pharma Packaging Remove Recombinant DNA Technology Related Topics
Packaging DNA Containment Gene Therapy FDA Approval Gene Vaccine Vaccination Drugs Packaging More Related Topics >
article thumbnail

What is the Difference Between Biologics and Biosimilars?

Pharma Packaging Solutions

SEPTEMBER 22, 2023

There are a few common types of biologics, including extracted (taken directly from a living system), semi-synthesized (produced with recombinant DNA technology), vaccines, and gene therapies. Because biosimilars have a more streamlined development process than biologics, they are typically more affordable.

Recombinant DNA Technology 52
Recombinant DNA Technology Packaging Packaging Pharma Packaging 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024